<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240311061251N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-07-16</date_registration>
      <primary_sponsor>Gorgan University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Group Internet-Delivered Mindfulness Based Cognitive Therapy (MBCT)  in Breast Cancer Patients</public_title>
      <acronym></acronym>
      <scientific_title>comparison of effectiveness of group internet-delivered Mindfulness Based Cognitive Therapy in anxiety , depression and level of mindfulness in breast cancer patients receiving chemotherapy with the control group: a randomized controlled clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/76926</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: randomization technique is simple randomization. unit of randomization is individual participants. randomization tool is table of random numbers. Before starting of the study, Random numbers are generated using www.random.org by a member of the team who does not participate in the study.

allocation concealment is done by sealed opaque envelopes. generated random numbers will be kept in sealed opaque envelopes until the start of the study. Allocation concealment will be maintained until the participant completes the demographic checklist. At this stage, the interviewer opened the sealed envelope to reveal the study group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: اختلال خلقی ناشی از وضعیت فیزیولوژیک شناخته شده با خصوصیات افسردگی. Condition 2: اختلال اضطرابی ناشی از وضعیت فیزیولوژیک شناخته شده.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group : Pre-test with Beck Depression Inventory - Second Edition (BDI-II), Beck Anxiety Inventory (BAI) and Five Facet Mindfulness Questionnaire (FFMQ) will be implemented in both intervention and control groups. The intervention group are subjected to  eight sessions of ninety minute weekly group internet-delivered Mindfulness Based Cognitive Therapy (iMBCT) in two groups of 15 participants. The iMBCT program is taken from the original version of Mindfulness-Based Cognitive Therapy from Segal et al.,2013 Handbook. then the post-tests will be administered in both groups. Intervention 2: Control group: Pre-test with Beck Depression Inventory - Second Edition (BDI-II), Beck Anxiety Inventory (BAI) and Five Facet Mindfulness Questionnaire (FFMQ) will be implemented. During period of time that intervention group is recieving therapy, the control group is under usual care and does not receive any intervention. then the post-tests will be administered in both intervention and control groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nazli Shaarbaf</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 19,3rd Amini Alley, Janbaz14 Ave., Janbazan Blvd., Gorgan</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4916657661</zip>
        <telephone>00981749206</telephone>
        <email>shaarbaf@goums.ac.ir</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nazli Shaarbaf</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.19 , 3rd amini alley , Janbaz14 Ave. , Janbazan Blvd.,Gorgan Town</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4916657661</zip>
        <telephone>+98 17 3234 9206</telephone>
        <email>shaarbaf@goums.ac.ir</email>
        <affiliation>Gorgan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Breast cancer diagnosed by oncologist and based on pathology report
The person must have basic internet and computer skills
Access to the Internet at a suitable speed
Age 20 to 55 years</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>55 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>The presence of another concurrent cancer
Having full criteria for other psychological disorders based on the researcher's clinical interview in accordance with DSM5 criteria
Being under drug or non-drug treatment for psychiatric diseases
Substance or alcohol abuse
Having Active Suicidal or Homicidal ideas
Low Performance Level related to cancer (equation  ECOG 3 and 4) , which is determined by the Oncologist based on the ECOG Scale (the Eastern Cooperative Oncology Group Scale)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F06.31</hc_code>
      <hc_code>F06.4</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Mood disorder due to known physiological condition with depressive features</hc_keyword>
      <hc_keyword>Anxiety disorder due to known physiological condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group : Pre-test with Beck Depression Inventory - Second Edition (BDI-II), Beck Anxiety Inventory (BAI) and Five Facet Mindfulness Questionnaire (FFMQ) will be implemented in both intervention and control groups. The intervention group are subjected to  eight sessions of ninety minute weekly group internet-delivered Mindfulness Based Cognitive Therapy (iMBCT) in two groups of 15 participants. The iMBCT program is taken from the original version of Mindfulness-Based Cognitive Therapy from Segal et al.,2013 Handbook. then the post-tests will be administered in both groups.</i_keyword>
      <i_keyword>Control group: Pre-test with Beck Depression Inventory - Second Edition (BDI-II), Beck Anxiety Inventory (BAI) and Five Facet Mindfulness Questionnaire (FFMQ) will be implemented. During period of time that intervention group is recieving therapy, the control group is under usual care and does not receive any intervention. then the post-tests will be administered in both intervention and control groups.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Anxiety score in Beck Anxiety Inventory. Timepoint: The beginning of the study (before the intervention) and the end of the study (after the intervention). Method of measurement: Beck Anxiety Inventory.</prim_outcome>
      <prim_outcome>Depression score in Beck depression Inventory - second edition. Timepoint: The beginning of the study (before the intervention) and the end of the study (after the intervention). Method of measurement: Beck depression Inventory - second edition.</prim_outcome>
      <prim_outcome>Mindfulness level in Five Facet Mindfulness Questionnaire. Timepoint: The beginning of the study (before the intervention) and the end of the study (after the intervention). Method of measurement: Five Facet Mindfulness Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Gorgan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-03-06</approval_date>
        <contact_name>Ethics committee of Golestan University of Medical Sciences</contact_name>
        <contact_address>No.14, 3rd Amini Alley, 14 janbaz Ave.,Janbazan Blvd.,Gorgan Town Gorgan Golestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
